chartexchange

Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update

GlobeNewswire Inc. | Nov 16, 2026 8:00 AM EST

NORCROSS, Ga., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended September 30, 2026.

Read original article